Correlation Between Dermata Therapeutics and Caribou Biosciences

Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dermata Therapeutics Warrant and Caribou Biosciences, you can compare the effects of market volatilities on Dermata Therapeutics and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Caribou Biosciences.

Diversification Opportunities for Dermata Therapeutics and Caribou Biosciences

0.0

Correlation Coefficient

Dermata Therapeutics  Caribou Biosciences

Pay attention - limited upside

The 3 months correlation between Dermata and Caribou is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics Warrant and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics Warrant are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Caribou Biosciences go up and down completely randomly.

Pair Corralation between Dermata Therapeutics and Caribou Biosciences

Assuming the 90 days horizon Dermata Therapeutics Warrant is expected to generate 24.55 times more return on investment than Caribou Biosciences. However, Dermata Therapeutics is 24.55 times more volatile than Caribou Biosciences. It trades about 0.15 of its potential returns per unit of risk. Caribou Biosciences is currently generating about -0.03 per unit of risk. If you would invest  2.33  in Dermata Therapeutics Warrant on October 3, 2024 and sell it today you would lose (0.85) from holding Dermata Therapeutics Warrant or give up 36.48% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	56.57%
Values	Daily Returns

Dermata Therapeutics Warrant  vs.  Caribou Biosciences

Dermata Therapeutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Dermata Therapeutics Warrant are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Dermata Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Caribou Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Caribou Biosciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Dermata Therapeutics and Caribou Biosciences

The main advantage of trading using opposite Dermata Therapeutics and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.

The idea behind Dermata Therapeutics Warrant and Caribou Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.